BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 10736427)

  • 1. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells.
    Desai SH; Boskovic G; Eastham L; Dawson M; Niles RM
    Biochem Pharmacol; 2000 May; 59(10):1265-75. PubMed ID: 10736427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
    Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
    Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
    Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
    Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma cell growth inhibition and melanocortin receptor downregulation induced by selective and non-selective retinoids.
    Siegrist W; Hintermann E; Roggo CN; Apfel CM; Klaus M; Eberle AN
    Melanoma Res; 1998 Apr; 8(2):113-22. PubMed ID: 9610863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
    Wan H; Oridate N; Lotan D; Hong WK; Lotan R
    Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
    Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
    Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid.
    Dawson MI; Zhang XK
    Curr Med Chem; 2002 Mar; 9(6):623-37. PubMed ID: 11945128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both retinoic-acid-receptor- and retinoid-X-receptor-dependent signalling pathways mediate the induction of the brown-adipose-tissue-uncoupling-protein-1 gene by retinoids.
    Alvarez R; Checa M; Brun S; ViƱas O; Mampel T; Iglesias R; Giralt M; Villarroya F
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):91-7. PubMed ID: 10600643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
    Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid-induced AP-1 transcriptional activity regulates B16 mouse melanoma growth inhibition and differentiation.
    Huang Y; Boskovic G; Niles RM
    J Cell Physiol; 2003 Feb; 194(2):162-70. PubMed ID: 12494454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of retinoic acid-receptor-independent retinoid X-receptor-dependent pathway in myeloid cell function.
    Hida T; Tai K; Tokuhara N; Ishibashi A; Kikuchi K; Hibi S; Yoshimura H; Nagai M; Yamauchi T; Kobayashi S
    Jpn J Pharmacol; 2001 Jan; 85(1):60-9. PubMed ID: 11243576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
    de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
    Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells.
    Clifford JL; Petkovich M; Chambon P; Lotan R
    Mol Endocrinol; 1990 Oct; 4(10):1546-55. PubMed ID: 2178220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway.
    Dawson MI; Elstner E; Kizaki M; Chen DL; Pakkala S; Kerner B; Koeffler HP
    Blood; 1994 Jul; 84(2):446-52. PubMed ID: 8025272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression.
    Yang L; Munoz-Medellin D; Kim HT; Ostrowski J; Reczek P; Brown PH
    Breast Cancer Res Treat; 1999 Aug; 56(3):277-91. PubMed ID: 10573118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.